跳至主要内容
临床试验/NCT03975543
NCT03975543Unknown不适用

Natural History Study of Retinitis Pigmentosa in Patient Carrying Pathogenic Mutations in RHO, PDE6A or PDE6B.

SparingVision1 个研究点 分布在 1 个国家目标入组 113 人开始时间: 2018年10月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
SparingVision
入组人数
113
试验地点
1
主要终点
Fundus Autofluorescence (FAF)

研究概览

简要总结

This is natural history study of rods and cones degenerations in patients with Retinitis Pigmentosa (RP) caused by pathogenic mutations in RHO, PDE6A or PDE6B gene mutations.

详细描述

This is a retrospective, longitudinal, observational case history study to determine the natural history of rods and cones degeneration in patients diagnosed with RP caused by pathogenic mutations in genes with selective expression in rods: rhodopsin (RHO), phosphodiesterase 6A (PDE6A) or phosphodiesterase 6B (PDE6B).

113 participants will be enrolled in this study at the single center: CHNO-CIC Quinze-Vingt Paris in France.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients with RP caused by pathogenic mutations in RHO, PDE6A or PDE6B genes.

排除标准

  • Patients with a pathogenic mutation in any other gene known to be involved in RP.
  • Patients with any ocular disorder other than RP, likely to impact the retinal function.

结局指标

主要结局

Fundus Autofluorescence (FAF)

时间窗: 2 years

Progression of disease as measured by FAF (Hyperautofluorescent ring)

Spectral Domain Optical Coherence tomography (SD-OCT)

时间窗: 2 years

Progression of disease over time as measured by SD-OCT (EZ length, ELM length, ONL thickness, macular volume).

Visual acuity

时间窗: 2 years

Progression of disease over time as measured by best corrected visual acuity (BCVA) (ETDRS, Snellen) and refraction

Visual field

时间窗: 2 years

Progression of disease over time as measured by visual fields (kinetic and static)

次要结局

  • Patients characteristics(2 years)
  • Electroretinogram (ERG)(baseline (At diagnosis))
  • Color vision(2 years)
  • Clinical diagnosis(baseline (At diagnosis))
  • Genetic diagnosis(baseline (At diagnosis))

研究者

发起方
SparingVision
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验